ライフサイエンスコーパス: ambulatory

1 patients who are symptom limited but remain ambulatory.

2 in this group (clinic -0.2 mmHg [-2.2, 1.8]; ambulatory 1.1 mmHg [-0.3, 2.5]).

3 Ambulatory 24-hour esophageal pH monitoring documented a

4 rred in 54 patients (with a robust change in ambulatory ability in 22) attributable to immunotherapy;

5 ember 17, 2008, and February 28, 2015, at an ambulatory academic medical center.

6 reduction in exercise performance and daily ambulatory activity irrespective of their limb symptoms

7 utive days during each intervention, and the ambulatory activity pattern was recorded (ambulatory ene

8 prevent falls or fractures in this healthy, ambulatory, adult population.

9 Among ambulatory adults aged 75 years or older, treating to an

10 Ninety ambulatory adults diagnosed with manifest Huntington dis

11 Ambulatory adults on warfarin with an INR target of 2-3

12 Ambulatory adults with heart failure from 3 integrated h

13 ce and Medical Management) demonstrated that ambulatory advanced heart failure patients selected for

14 At 1 year, only 47% of this ambulatory advanced HF cohort remained alive on medical

15 In total, 804647 (95% CI, 662075-947218) ambulatory and 49790 (95% CI, 38318-61262) diplopia-rela

16 was ordered in 6.2% (95% CI, 2.8%-12.9%) of ambulatory and 59.7% (95% CI, 38.6%-77.7%) of ED visits,

17 New data have emerged from ambulatory and acute care settings about adverse patient

18 Numbers of ambulatory and ED diplopia presentations were estimated

19 Ambulatory and ED visits in the United States by patient

20 To describe diplopia presentations in US ambulatory and emergency department (ED) settings.

21 nics, primary care and referral centers, and ambulatory and hospitalized care.

22 statistics on health care utilization in the ambulatory and inpatient setting along with data on canc

23 Trials and observational studies in ambulatory and inpatient settings reporting process-of-c

24 l on process-of-care and patient outcomes in ambulatory and inpatient settings.

25 nt reductions in systolic and diastolic 24-h ambulatory and nighttime BP (p < 0.01) were observed wit

26 engue cases is 18% admitted to hospital, 48% ambulatory, and 34% non-medical.

27 ons (revisits) were identified in inpatient, ambulatory, and emergency department settings across eac

28 s in various conditions including emergency, ambulatory, and remote area.

29 rdised clinical data including the NorthStar Ambulatory Assessment score (NSAA) on 513 ambulant UK bo

30 ngle time point, and summarize findings from ambulatory assessment studies suggesting that such desig

31 lt patients who owned a smartphone, who were ambulatory at baseline, and who remained in ICU for more

32 mg daily, with HCTZ, 12.5 mg daily, by 24-h ambulatory blood pressure (ABP) monitoring and evaluated

33 plant to estimate the prevalence of abnormal ambulatory blood pressure (ABP), assess factors associat

34 ated whether intact milk proteins lower 24-h ambulatory blood pressure (AMBP) and other risk markers

35 Ambulatory blood pressure (BP) monitoring is the referen

36 This article reviews the clinical value of ambulatory blood pressure (BP) vis-a-vis the traditional

37 ERI was measured using validated scales, and ambulatory blood pressure (BP) was measured every 15 min

38 Twenty-four-hour urine collections and 24-h ambulatory blood pressure assessments were performed at

39 Office and 24-h ambulatory blood pressure levels were not changed.

40 ccuracy of pulse intervals detected using an ambulatory blood pressure monitor (ABPM) with single lea

41 suring blood pressure outside of the clinic: ambulatory blood pressure monitoring (ABPM) and home blo

42 The clinical relevance of ambulatory blood pressure monitoring (ABPM) for risk str

43 Ambulatory blood pressure monitoring (ABPM) is the prefe

44 on, carotid intimal-media thickness (c-IMT), ambulatory blood pressure monitoring (BP), fasting plasm

45 TnT can identify people who may benefit from ambulatory blood pressure monitoring or hypertension pre

46 stric bypass, considering office and 24-hour ambulatory blood pressure monitoring, respectively, wher

47 e of 140 mm Hg or higher and average daytime ambulatory blood pressure of 135 mm Hg or higher systoli

48 od pressure during the intervention and 24-h ambulatory blood pressure on day 7 of the intervention.

49 Office and ambulatory blood pressure outcomes did not differ betwee

50 Mean systolic 24 h ambulatory blood pressure reduced by 13.5 (18.8) mm Hg (

51 outcome was placebo-corrected 24-h systolic ambulatory blood pressure reduction after 4 weeks and an

52 Mean baseline 24 h ambulatory blood pressure was 166/100 mm Hg (17/14) at b

53 differences in home blood pressure and 24-h ambulatory blood pressure were observed with 1-wk intake

54 d lipid profiles, inflammatory markers, 24-h ambulatory blood pressure, and carotid artery intimamedi

55 ndpoints included changes in office and 24 h ambulatory blood pressure.

56 They reported smaller reductions in ambulatory blood pressures (11.2 mm Hg; 95% CI, 10.0 to

57 A total of 109 ambulatory boys with DMD (8.7 +/- 2.0 years; range, 5.0-

58 ssess the efficacy and safety of ataluren in ambulatory boys with nonsense mutation DMD.

59 systematic differences between clinic BP and ambulatory BP (ABP) in a community sample of employed ad

60 with normal office BP, those with increased ambulatory BP (masked hypertension) have an increased pr

61 ta support no further reduction in office or ambulatory BP after 1-year follow-up.

62 guided by office BP, a treatment tailored on ambulatory BP allows to improve prevention or regression

63 he primary outcomes-change in mean clinic or ambulatory BP and proportion controlled below target at

64 Ambulatory BP data at 12 months were available from 4 tr

65 nt technique on BP readings, and explore how ambulatory BP data from the SPRINT trial may inform this

66 BP, a potential therapeutic target requiring ambulatory BP evaluation, might be a significant method

67 The prognostic value of clinic and ambulatory BP in predicting incident CKD and whether CKD

68 estricted to 1016 participants who completed ambulatory BP monitoring at baseline in 2000 to 2004.

69 ated the prevalence of MUCH as determined by ambulatory BP monitoring using three definitions of hype

70 ic/diastolic BP <140/90 mm Hg, who completed ambulatory BP monitoring, were free of cardiovascular di

71 onfirmation of MUCH diagnosis should rely on ambulatory BP monitoring.

72 treated hypertension was defined as daytime ambulatory BP of at least 135/85 mm Hg and was further d

73 n or in hypertensive cohorts have shown that ambulatory BP provides a more accurate prediction of out

74 D age: 51.5+/-14.3 years old), with baseline ambulatory BP ranging from normotension to hypertension.

75 Agreement in MUCH diagnosis by ambulatory BP was 75-78% (kappa coefficient for agreemen

76 of mean clinic BP and mean awake or 48-hour ambulatory BP was not significant when corrected by mean

77 techin did not change BP (office BP and 24-h ambulatory BP), arterial stiffness, nitric oxide, endoth

78 nsion treatment was adjusted on the basis of ambulatory BP), we simultaneously monitored BP and physi

79 The prevalence of MUCH was 26.7% by daytime ambulatory BP, 32.8% by 24-hour ambulatory BP, 56.1% by

80 % by daytime ambulatory BP, 32.8% by 24-hour ambulatory BP, 56.1% by daytime or night-time ambulatory

81 mbulatory BP, 56.1% by daytime or night-time ambulatory BP, and 50.8% by home BP.

82 cardiovascular events than those with normal ambulatory BP.

83 endent of changes in mean clinic BP or awake ambulatory BP.

84 Patients undergoing ambulatory breast reconstruction can use follow-up care

85 troke, and presence or absence of post-index ambulatory cardiac monitoring.

86 ing cardiovascular health and the quality of ambulatory cardiovascular care provided in Ontario, Cana

87 of growth in spending in absolute terms were ambulatory care among all types of care and inpatient we

88 was conducted at the clinical offices in the ambulatory care area of a hospital.

89 cohort study using medical claims data from ambulatory care centers across the United States that we

90 Cohorts from ambulatory care centers across the United States were cr

91 domized, double-blind trial was conducted at ambulatory care centers at the University of Minnesota (

92 In a cross-sectional study, conducted in an ambulatory care clinic and hospital, comparing 69 cirrho

93 presented with acute respiratory illness at ambulatory care clinics in geographically diverse U.S. s

94 ly of cellulitis account for $3.7 billion in ambulatory care costs alone.

95 a randomized clinical trial was conducted in ambulatory care dermatologic offices from June 6, 2011,

96 ered by attending physicians in a variety of ambulatory care environments.

97 sed of patients diagnosed with NAION seeking ambulatory care from 2000 to 2011.

98 nic care model designed to shift delivery of ambulatory care from acute, episodic, and reactive encou

99 ergoing breast reconstruction at an academic ambulatory care hospital.

100 Setting: U.S. ambulatory care in 4 specialties in 4 states (Illinois,

101 -We conducted the Cardiovascular Health in Ambulatory Care Research Team (CANHEART) Immigrant study

102 The CArdiovascular HEalth in Ambulatory care Research Team (CANHEART) is conducting a

103 using the CANHEART (Cardiovascular Health in Ambulatory Care Research Team) dataset, which was create

104 for TPM; IRR, 0.89 [95% CI, 0.85 to 0.94]), ambulatory care sensitive visits and admissions (3.3 for

105 h a median follow-up time of 35 months in an ambulatory care setting in 5 US academic referral instit

106 disease relapse in 742 children with ALL in ambulatory care settings of 94 participating institution

107 ed vaccine effectiveness (VE) estimates from ambulatory care settings were markedly decreased.

108 treatment and cure with rates comparable to ambulatory care settings, implementation of ED HCV scree

109 higher than reports from similar studies in ambulatory care settings, suggesting that the 2014-2015

110 mab, metronidazole, hospitalizations, higher ambulatory care visits, shorter duration of IBD, and hig

111 cations in children presenting in primary or ambulatory care with influenza or influenza-like illness

112 ality on pediatric hospitalization rates for ambulatory care-sensitive conditions (ACSCs) and whether

113 nt and associated 30-day postacute costs for ambulatory care-sensitive conditions (ACSCs).

114 uticals and 23.5% (UI, 21.7%-25.7%) spent on ambulatory care.

115 own about how physician time is allocated in ambulatory care.

116 ions between ESF coverage and mortality from ambulatory-care-sensitive conditions (ACSCs) in black/pa

117 The number of patients requiring ambulatory chemotherapy is increasing year on year, crea

118 with New York Heart Association class III or ambulatory class IV HF, EF >/=40%, exercise PCWP >/=25 m

119 es were collected in Phoenix, Arizona, at an ambulatory clinic and at retail outlets with point-of-ca

120 t dyads of hospital-based pediatric oncology ambulatory clinics and inpatient units between September

121 activity of HD neurons is influenced by the ambulatory constraints imposed upon the animal by the bo

122 ne and after 2 weeks of treatment using 24 h ambulatory cough recordings.

123 ge, prospective, genotype-phenotype study of ambulatory DCM patients, we show that prognostic factors

124 ed >/=18 years with a hospital (inpatient or ambulatory) diagnosis of AD or psoriasis during the stud

125 Secondary end points included change in ambulatory diastolic blood pressure and clinic systolic

126 (95% CI 0.56-5.56 mmHg, p = 0.017) and mean ambulatory diastolic blood pressure was 2.17 mmHg lower

127 Ambulatory DMD patients who were >/=7 years old and amen

128 bulatory pediatric cardiology for a range of ambulatory domains.

129 Respiratory and ambulatory dysfunction are prominent features in patient

130 1 year of follow-up, only 2.6% and 9.7% had ambulatory ECG monitoring in the 7 days and 12 months po

131 ICDs were interrogated and ambulatory ECGs monitored for NSVT episodes, with associ

132 ticipants who were randomly assigned to 24-h ambulatory electrocardiography (Holter) monitoring and w

133 Study subjects underwent 48-h ambulatory electrocardiography, fasting blood tests, and

134 We evaluated ambulatory encounter claims of Medicaid-insured children

135 he ambulatory activity pattern was recorded (ambulatory energy expenditure estimation).

136 ients who cannot reduce PPIs should consider ambulatory esophageal pH/impedance monitoring before com

137 Ambulatory expenses accounted for the largest proportion

138 ifornia hospital-owned and nonhospital-owned ambulatory facilities, emergency departments, and hospit

139 Patients with ALS underwent ambulatory follow-up at the same department.

140 Initial hospitalization with ambulatory follow-up occurred in 17 French centers.

141 Advanced PAD leads to a decline in ambulatory function and diminished quality of life.

142 ontributor to the decline in respiratory and ambulatory function in Pompe and arises from both pre- a

143 ular Assist Device and Medical Management in Ambulatory Heart Failure Patients) is a prospective, mul

144 died 972 Resynchronization/Defibrillation in Ambulatory Heart Failure Trial (RAFT) participants witho

145 The RAFT (Resynchronization in Ambulatory Heart Failure Trial) demonstrated that cardia

146 nce to EX was determined from exercise logs, ambulatory heart rate recordings of exercise, and weekly

147 As in clinical trials, use of ambulatory hemodynamic monitoring in clinical practice i

148 This study examined the effectiveness of ambulatory hemodynamic monitoring in reducing HFH outsid

149 comes of Exercise Training) randomized 2,331 ambulatory HF patients with ejection fraction </=35% to

150 Using a cohort of well-treated ambulatory HF patients with reduced ejection fraction wh

151 s been tremendous advancement in therapy for ambulatory HF with reduced ejection fraction with the us

152 33% of New York State clinicians who provide ambulatory HIV care are LVPs.

153 CHARTER is an observational study of ambulatory HIV-infected adults.

154 Ambulatory HIV-infected patients without active tubercul

155 luding standard clinical data and continuous ambulatory human data obtained over several years using

156 Thresholds for identifying ambulatory hypertension (daytime systolic BP [SBP]/diast

157 We determined BP thresholds for ambulatory hypertension in a US population-based sample

158 iated with abnormal ABP, and examine whether ambulatory hypertension is associated with worse allogra

159 me, 24-hour, and nighttime BP thresholds for ambulatory hypertension were identified using regression

160 assess the feasibility and safety of AATP in ambulatory ICD patients.

161 Ambulatory impedance testing underestimates acid reflux

162 In this way Mtb infection can result in an ambulatory individual who has a lesion in the lung capab

163 cted on kaggle.com using open access chronic ambulatory intracranial electroencephalography from five

164 New York Heart Association class II, III, or ambulatory IV symptoms despite treatment with guideline-

165 Ambulatory laparoscopic appendectomy (LA) for AA has not

166 Using the 2010-2011 National Ambulatory Medical Care Survey and National Hospital Amb

167 prespecified secondary analysis of National Ambulatory Medical Care Survey and National Hospital Amb

168 nts with PAD were obtained from the National Ambulatory Medical Care Survey and National Hospital Amb

169 ry Medical Care Survey and National Hospital Ambulatory Medical Care Survey data collected for a 10-y

170 of appendicitis, using the National Hospital Ambulatory Medical Care Survey from 2003 to 2010.

171 ry Medical Care Survey and National Hospital Ambulatory Medical Care Survey, a nationally representat

172 ry Medical Care Survey and National Hospital Ambulatory Medical Care Survey, annual numbers and popul

173 Analysis of data from the National Hospital Ambulatory Medical Care Survey.

174 for 13832 office visits (2010-2013 National Ambulatory Medical Care Surveys) and 108472 hospital sta

175 that noted on the Space Shuttle and in adult ambulatory medicine, except that usage of sleep aids was

176 ere significantly increased in patients with ambulatory mild ALD as compared to nonalcoholics.

177 severe aortic stenosis who were seen in the ambulatory Minneapolis Heart Institute at Abbott Northwe

178 toward the implementation of decentralized, ambulatory models of care.

179 Agreement between preimplant ambulatory monitoring and ICD interrogation for detectin

180 CDs), of whom 94 patients had 24- to 48-hour ambulatory monitoring preimplant.

181 an 24 h blood pressure of >/=130/80 mm Hg by ambulatory monitoring within 1 week of randomisation) an

182 runs of NSVT, including 17 before implant on ambulatory monitoring, 44 after ICD implantation, and 22

183 e clinic setting and elevated BP assessed by ambulatory monitoring, is associated with increased risk

184 he impact on the AF severity scale and 7-day ambulatory monitoring.

185 the human MTL during untethered, real-world ambulatory movement.

186 t versus optimal medical management (OMM) in ambulatory New York Heart Association functional class I

187 The change in mean ambulatory nighttime blood pressure from randomization s

188 documented BP>140/90 mmHg measured during an ambulatory, nonemergency department visit--during follow

189 A cohort (n = 843) of ambulatory older men without prevalent atrial fibrillati

190 suspicion for EFE, as patients are typically ambulatory on presentation without systemic signs of inf

191 t least 4 hours starting in the morning with ambulatory one-lead ECG monitors.

192 h were used to adjust for age, BMI, smoking, ambulatory or hospitalized state, and calendar time, sho

193 plasma exchange, and immunosuppressants) and ambulatory outcomes were compared between different subg

194 At the ambulatory outpatient clinics of the Victorian Clinical

195 sis (hereafter, "hospitalized patients"), 58 ambulatory outpatients with HIV infection and newly diag

196 ulatory patients with tuberculosis"), and 58 ambulatory outpatients with HIV infection and without tu

197 clusion: Primary care physicians with busier ambulatory patient practices delivered lower-quality dia

198 Primary care physicians with busier ambulatory patient practices delivered lower-quality dia

199 ngle-lead iECG with remote interpretation in ambulatory patients >/=65 years of age at increased risk

200 h severe limitation was less common than for ambulatory patients enrolled in INTERMACS before ventric

201 ed from February 1 to August 31, 2015, among ambulatory patients undergoing breast reconstruction at

202 INTERMACS profiles help identify ambulatory patients with advanced HF who may benefit fro

203 stimate more than 50% 1-year mortality among ambulatory patients with heart failure who die in the su

204 death declined substantially over time among ambulatory patients with heart failure with reduced ejec

205 modified sandwich immunoassay in consecutive ambulatory patients with HF who were followed up for 4.1

206 patients with HD screened for the study, 37 ambulatory patients with manifest HD (mean [SD] age, 52.

207 nt consensus guidelines for the treatment of ambulatory patients with mild to severe active UC.

208 High-risk ambulatory patients with New York Heart Association clas

209 Ambulatory patients with systolic HF, a heavy symptom bu

210 nd newly diagnosed tuberculosis (hereafter, "ambulatory patients with tuberculosis"), and 58 ambulato

211 mong hospitalized patients, 19.1 ng/mL among ambulatory patients with tuberculosis, and 5.9 ng/mL amo

212 ients with tuberculosis, and 5.9 ng/mL among ambulatory patients without tuberculosis (P < .001).

213 ection and without tuberculosis (hereafter, "ambulatory patients without tuberculosis").

214 Of 10 ambulatory patients, 5 died from untreated VF, 4 had car

215 WiFi-enabled iPod to obtain ECGs (iECGs) in ambulatory patients.

216 reatment of early neurologic Lyme disease in ambulatory patients.

217 cycline for early neurologic Lyme disease in ambulatory patients.

218 ting) and Current Procedural Terminology and Ambulatory Payment Classification codes (nonadmission) w

219 resulted in successful development of QMs in ambulatory pediatric cardiology for a range of ambulator

220 The ACPC sought to develop QMs for ambulatory pediatric cardiology practice.

221 attempted to create quality metrics (QM) for ambulatory pediatric practice, but limited evidence made

222 ly recommended decreases indexes of IR in an ambulatory population of overweight elderly subjects.

223 In an ambulatory population with no history of cardiovascular

224 ients with polyneuropathy and to controls in ambulatory practice between January 1, 2006, and Decembe

225 prospective case series was conducted at the ambulatory practice of a hospitalist between January 1,

226 : To describe how physician time is spent in ambulatory practice.

227 Ambulatory rates at 1 month were 71.8% and 74.0%, respec

228 four drugs in the bloodstream of even awake, ambulatory rats, achieving precise molecular measurement

229 y data from a study that acquired continuous ambulatory recordings in humans over extended periods of

230 n, annual health care spending on inpatient, ambulatory, retail pharmaceutical, nursing facility, eme

231 ey-protein supplementation also lowered 24-h ambulatory SBP and DBP.

232 n self-monitoring and either lower clinic or ambulatory sBP in this group (clinic -0.2 mmHg [-2.2, 1.

233 DBP) of 90 mm Hg or greater, and a mean 24-h ambulatory SBP of 140 mm Hg or greater and less than 170

234 the results in the context of outcomes from ambulatory screening venues where 2%-10% of chronically

235 ; or cataract; 2.02 million) in California's Ambulatory Services Databases.

236 ity of a serious neurologic diagnosis in the ambulatory setting and higher probability in an ED, futu

237 ts, and diagnoses were rarely serious in the ambulatory setting but potentially life threatening in 1

238 st 4 million diagnoses of hemorrhoids in the ambulatory setting in a year.

239 equent diagnoses was life threatening in the ambulatory setting, but approximately 16% of diplopia-re

240 e; the care of cardiovascular disease in the ambulatory setting, including medical strategies for vas

241 are as the control, and 14 took place in the ambulatory setting.

242 onsumer Assessment of Health Plans Survey in ambulatory settings is incorporated as a complementary v

243 ngth evidence suggested that P4P programs in ambulatory settings may improve process-of-care outcomes

244 sidents receive training in well-functioning ambulatory settings that are financially supported for t

245 RCTs of adults with low back pain treated in ambulatory settings with SMT compared with sham or alter

246 Among 69 studies, 58 were in ambulatory settings, 52 reported process-of-care outcome

247 ssociated with improved processes of care in ambulatory settings, but consistently positive associati

248 in a wide variety of roles in inpatient and ambulatory settings, largely through optimization of dru

249 and skin-structure infections are common in ambulatory settings.

250 from hospitalized infants and those seen in ambulatory settings.

251 encounter, including hospital admissions and ambulatory settings.

252 P1074 were eligible, and 1446 PHIVY from 41 ambulatory sites in the 12 US states, including Puerto R

253 logy services of 2 VA medical facilities for ambulatory skin conditions from December 2008 through Ju

254 characteristics of theta oscillations during ambulatory spatial navigation, while highlighting some f

255 improvement at 6 months postoperatively for ambulatory status (McNemar test, P < .001), lower extrem

256 age (sICH), in-hospital mortality, discharge ambulatory status, and modified Rankin Scale score (rang

257 Other study end points included ambulatory status, local progression-free survival, and

258 Patients were stratified according to ambulatory status, time developing motor deficits, and p

259 characteristics, and disability measured by ambulatory status.

260 d in the prevention of skin infections after ambulatory surgeries and as a maintenance therapy of ato

261 of management of acute appendicitis (AA) in ambulatory surgery (AmbSurg) on the basis of preoperativ

262 Data on costs of SSIs following ambulatory surgery are sparse, particularly variation be

263 geries in the United States are performed in Ambulatory Surgery Center (ASC) and Hospital Outpatient

264 1 at 36 community acute care hospitals and 1 ambulatory surgery center in the Duke Infection Control

265 of an elective hernia repair performed in an ambulatory surgery center.

266 nned hospital visits were comparable between ambulatory surgery centers and hospital outpatient depar

267 All hospitals and ambulatory surgery centers in New York State were includ

268 Using four state-level inpatient and ambulatory surgery databases, we conducted a retrospecti

269 observational cohort study at inpatient and ambulatory surgery settings in New York State.

270 from California, Florida, and New York state ambulatory surgery settings were identified using ICD-9-

271 ia residents >/=21 years of age who received ambulatory surgery, emergency, or inpatient medical care

272 ucted a retrospective cohort study using the ambulatory surgery, inpatient, and emergency department

273 ollow-up care in the first 30 days following ambulatory surgery.

274 in a hospital/facility-based and nonfacility/ambulatory surgical center (ASC)-based setting.

275 METHODS AND Data were extracted from State Ambulatory Surgical Database and State Inpatient Databas

276 (SSIs) on health care costs following common ambulatory surgical procedures throughout the cost distr

277 mean change from baseline in office and 24 h ambulatory systolic blood pressure at 6 months.

278 The difference in the change in daytime ambulatory systolic blood pressure from baseline to 6 mo

279 For secondary analyses, adjusted mean ambulatory systolic blood pressure was 3.06 mmHg lower (

280 The between-patient variability of daytime ambulatory systolic blood pressure was greater for nonad

281 re differences between treatments in daytime ambulatory systolic BP, flow-mediated dilation, and tota

282 ous tibial nerve stimulation (PTNS) is a new ambulatory therapy for faecal incontinence.

283 spital admission because of heart failure or ambulatory treatment for worsening heart failure.

284 We tested the hypothesis that ambulatory treatment with oral amoxicillin for 7 days wa

285 ars with genetically confirmed type 2 or non-ambulatory type 3 SMA.

286 of olesoxime in patients with type 2 or non-ambulatory type 3 SMA.

287 m of laminin-211 (Lm211) and are a model for ambulatory-type Lmalpha2-deficient muscular dystrophy.

288 d hindlimb paralysis, with animals remaining ambulatory until the humane endpoint, which was due to r

289 d validation in academic and community-based ambulatory urology clinics.

290 Half of our patients were able to achieve ambulatory vision at the last follow-up.

291 conservation is possible in most cases, with ambulatory vision retained in a small proportion of pati

292 8-year period, the average annual number of ambulatory visits in the United States for PAD was 3,883

293 Most diplopia-related ambulatory visits were conducted by ophthalmologists (70

294 elated ED visits occurred annually; 12.3% of ambulatory visits were primarily for acute- or subacute-

295 usted rates with 95% confidence intervals of ambulatory visits with oral antibiotic prescriptions by

296 Compared with ambulatory visits, remote monitoring (RM) of ICD recipie

297 were ascertained for each physician: overall ambulatory volume (representing time available to devote

298 Results: Higher overall ambulatory volume was associated with lower rates of app

299 Higher overall ambulatory volume was associated with lower rates of app

300 n (SD) patient age was 62.1 (20.3) years for ambulatory vs 48.1 (22.3) years for diplopia-related ED